MedPath

Lung Cancer Risk and Early Detection in Firefighters

Not Applicable
Recruiting
Conditions
Lung Cancer
Lung Diseases
Interventions
Diagnostic Test: Low Dose CT
Registration Number
NCT04614129
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study will evaluate whether LDCT findings differ between firefighters and non-fighters, the relationship between occupational exposures and LDCT findings, and whether a proteomics assay can further risk-stratify screen-detected nodules among a study population of 850 current and retired firefighters and 1,120 matched controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
850
Inclusion Criteria
  • 40-80 years of age or with 10 years of firefighting experience
  • Current or retired firefighters
  • No personal history of lung cancer
  • Willing and able to receive LDCT screening at MGH or who have been screened via LDCT within the past year at MGH or another institution, and are willing to release their images to the study
Exclusion Criteria
  • Any active cancer (undergoing treatment or diagnosed within the past 5 years)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Low-Dose CTLow Dose CTLow Dose CT Scan of the Chest
Primary Outcome Measures
NameTimeMethod
Nodule detection rate12 months

Frequency of nodule detection

High-risk nodule detection rate12 months

Frequency of high-risk nodule detection. High risk is defined as a Lung RADS of 3 or 4. Lung RADS categories are as follows: 0) Incomplete; 1) Negative; 2) Benign appearance or behavior; 3) Probably benign; 4) Suspicious

Secondary Outcome Measures
NameTimeMethod
Coronary artery calcification (CAC) ordinal scores12 months

Frequency of high coronary artery calcification (CAC) ordinal scores. Possible scores range from 0 to 12 and high scores are defined as those greater than or equal to 10

Interstitial lung disease detection rate12 months

Frequency of interstitial lung disease detection

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath